Aim. To estimate a 5- and 10-year survival according to age, and death-risk-associated factors, in a cohort of women diagnosed with cervical adenocarcinoma treated in the National Cancer Institute(INCA) in Brazil. Methods. A retrospective prognostic study was carried out in a hospital-based cohort of women diagnosed with cervical adenocarcinoma and treated in the Hospital of Cancer-II/INCA. From Jan/1999 to Dec/2012, 1060 women were included. Five- and 10-year survival curves were estimated by the Kaplan-Meier method. Differences between survival curves were assessed by log-rank test(IC95%). Prognostic factors were assessed by the Proportional Cox Regression semi-parametric method. The 95%CI for crude and adjusted Hazard Ratios were estimated by the Wald test. Results. Five-year survival was 45.4%, ranging from 62.6% among women aged 18-44 to 40.1% among 56+ years old. A 10-year specific survival was 50.1%, ranging from 61.6% in women aged 18-44-yr/o to 39.8% in those > 56-yr. Compared to women aged 45-55 years old, those with 18-44 years old presented a 25% higher death risk (95%CI:0.95-1.64) in 5 years, while those aged 56+ years old presented a 49% higher death risk in 10 years. Stage II (HR:1.67; IC95%:1.17-2.40), III (HR:3.10;95%CI:2.12–4.55), and IV (HR:3.03;95%CI:1.71–5.36), Grade-3 (HR:1.65;95%CI:1.21–2.27), Chemotherapy only/no-treatment (HR:3.13;95%CI:1.98–4.95), and 3-4 pregnancies (HR:0.73;95%CI:0.55-0.96) were independently associated with death-risk in 5 years. Ten-years death-risk was statistically associated with Stage II (HR:2.35; IC95%:1.41–3.92), III (HR:5.69;95%CI:3.26–9.92), and IV (HR:5.93; 95%CI:2.49-14.11), Grade-3 (HR:2.13; 95%CI:1.37–3.32), Chemotherapy only/no-treatment (HR:3.85;95%CI:1.96–7.54), without a partner (HR:1.50;95%CI:1.12–2.10), and non-white skin color (HR:1.43;95%CI:1.08–1.91). Conclusion. Despite the lack of statistical significance, women aged 18-44 years seemed to present a 25% worse prognosis in 5 years than women aged 45-55 years, but in 10 years those 56+ years presented a worse prognosis. Besides Stage, grade, and treatment, women with 3-4 pregnancies were protected against death in 5 years, while lack of a partner and non-white skin color increased death risk in 10 years.